SB 418: Health care coverage: prescription hormone therapy and nondiscrimination.

The bill aims to improve health care coverage for transgender, gender diverse, and intersex individuals by requiring health care service plans and health insurers to provide certain benefits and protections. The bill would require coverage for outpatient prescription drug benefits, including a 12-month supply of FDA-approved prescription hormone therapy, and prohibit utilization controls that limit the supply of this hormone therapy. It would also prohibit discrimination against individuals based on their sex, gender identity, or intersex traits, including exclusion from enrollment, denial of benefits, or subjecting individuals to certain actions. The bill would allow for certain exceptions and limitations, such as limiting refills in the last quarter of the year, and exclude Medi-Cal managed care plans from these requirements. The bill would repeal these provisions on January 1, 2035,…